Re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo. 2017.03.036

被引：0

作者：

Ayubi, Erfan ^{[1
,2
]}

Safiri, Saeid ^{[3
]}

机构：

[1] Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran

[2] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran

[3] Maragheh Univ Med Sci, Sch Nursing & Midwifery, Dept Publ Hlth, Managerial Epidemiol Res Ctr, Maragheh, Iran

来源：

EUROPEAN UROLOGY | 2017年 / 72卷 / 06期

关键词：

OPERATING CHARACTERISTIC CURVES; AREAS;

D O I：

10.1016/j.eururo.2017.05.031

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E157 / E157

页数：1

共 50 条

[1] Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues
Trocka, Bruce J.
Karnes, R. Jeffrey
[J]. EUROPEAN UROLOGY, 2017, 72 (06) : E158 - E159
[2] Re: Yaw A. Nyame, Matthew R. Cooperberg, Marcus G. Cumberbatch, et al. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2022.03.007
Wei, Yu
Ye, Dingwei
Zhu, Yao
[J]. EUROPEAN UROLOGY, 2022, 82 (02) : E51 - E51
[3] Re: Simpa S. Salami, Jeffrey J. Tosoian, Srinivas Nallandhighal, et al. Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.06.041
Orczyk, Clement
Marsden, Teresa
Emberton, Mark
[J]. EUROPEAN UROLOGY, 2021, 79 (03) : E98 - E99
[4] Re: Giorgio Gandaglia, Freddie Bray, Matthew R. Cooperberg, et al. Prostate Cancer Registries: Current Status and Future Directions. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.046
Stattin, Par
Robinson, David
Lambe, Mats
[J]. EUROPEAN UROLOGY, 2015, 68 (05) : E110 - E110
[5] Re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003
Vickers, Andrew J.
[J]. EUROPEAN UROLOGY, 2024, 86 (03) : e71 - e71
[6] Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.009
Plata, Mauricio
Cesar, Diaz Ritter
Badillo, Nicolas
[J]. EUROPEAN UROLOGY, 2023, 84 (01) : E24 - E25
[7] Re: Luca F. Valle, Eric J. Lehrer, Daniela Markovic, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.010
Kim, Sung Eun
Shin, Jae Il
Shoag, Jonathan Evan
[J]. EUROPEAN UROLOGY, 2021, 80 (01) : E14 - E14
[8] Re: Russell EN Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016
Iyer, Gopa
Bochner, Bernard H.
Van Allen, Eliezer M.
Solit, David B.
Rosenberg, Jonathan E.
[J]. EUROPEAN UROLOGY, 2021, 79 (02) : E56 - E57
[9] Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2020.04.038 Cytoreductive Nephrectomy: To Whom and When?
Mollica, Veronica
Rizzo, Alessandro
Massari, Francesco
[J]. EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (04): : 559 - 560
[10] Re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eur- uro.2021.03.009 Focus on Intraductal Carcinoma of the Prostate
Cimadamore, Alessia
Cheng, Liang
Lopez-Beltran, Antonio
Scarpelli, Marina
Montironi, Rodolfo
[J]. EUROPEAN UROLOGY, 2021, 80 (03) : E81 - E82

← 1 2 3 4 5 →